Quick Answer
ACRO BIOMEDICAL CO., LTD. reported Net Income Loss of -$101.1 thousand for the year ending 2025.
- ACRO BIOMEDICAL CO., LTD. showed a decrease of -139.1% in Net Income Loss from 2024 to 2025.
- This data is from ACRO BIOMEDICAL CO., LTD.'s annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2015 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2015 to 2025), ACRO BIOMEDICAL CO., LTD.'s Net Income Loss has declined by 113.0%.
- Historical annual values: Fiscal year 2025: -$101.1 thousand | Fiscal year 2024: -$42.3 thousand | Fiscal year 2023: -$8.81 million | Fiscal year 2022: -$15.87 million | Fiscal year 2021: -$7.70 million | Fiscal year 2020: -$117.5 thousand | Fiscal year 2019: -$371.6 thousand | Fiscal year 2019: -$370.7 thousand | Fiscal year 2018: $419.7 thousand | Fiscal year 2017: -$2.2 thousand | Fiscal year 2016: -$43.4 thousand | Fiscal year 2015: -$47.5 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: